GlassScriptPhysician profile
Farid A Hakim
NPI 1013002849
$9,794.38
in general payments reported to CMS, 2019-2025
17 companies · $866 in 2025
The $866 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,205 · 2020: $5,472 · 2021: $334 · 2022: $576 · 2023: $745 · 2024: $597 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,207.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team 1, LLC | $2,933.05 | 2020-2025 | |
| Arthrex, INC. | $2,861.57 | 2020-2025 | |
| Stryker Corporation | $1,661.87 | 2019-2025 | T2 Alpha, Mako, Pangea |
| Smith+Nephew, INC. | $438.88 | 2019-2021 | |
| Biotissue Holdings INC. | $412.33 | 2024-2025 | |
| Depuy Synthes Sales INC. | $352.92 | 2019-2023 | Na |
| Medacta USA, INC. | $316.21 | 2021-2024 | Reverse Shoulder |
| Zimmer Biomet Holdings, INC. | $199.02 | 2023 | Identity, Rosa |
| Davol INC. | $156.09 | 2023 | |
| Osteoremedies, LLC | $105.33 | 2025 | Remedy Spectrum Gv Spacer, Osteoboost Select 5cc, Remedy Spacer |
| Anika Therapeutics, INC. | $90.32 | 2020 | |
| Lima USA, INC. | $84.95 | 2022 | |
| Amniox Medical, INC. | $59.93 | 2019 | |
| Carbofix Orthopedics INC | $40.70 | 2020 | |
| Uoc USA INC | $39.66 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $22.04 | 2021 | |
| Ethicon US, LLC | $19.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farid Hakim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.